These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 38043609)

  • 1. An interpretable artificial intelligence framework for designing synthetic lethality-based anti-cancer combination therapies.
    Wang J; Wen Y; Zhang Y; Wang Z; Jiang Y; Dai C; Wu L; Leng D; He S; Bo X
    J Adv Res; 2024 Nov; 65():329-343. PubMed ID: 38043609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SLGNN: synthetic lethality prediction in human cancers based on factor-aware knowledge graph neural network.
    Zhu Y; Zhou Y; Liu Y; Wang X; Li J
    Bioinformatics; 2023 Feb; 39(2):. PubMed ID: 36645245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicting Synthetic Lethality in Human Cancers via Multi-Graph Ensemble Neural Network.
    Lai M; Chen G; Yang H; Yang J; Jiang Z; Wu M; Zheng J
    Annu Int Conf IEEE Eng Med Biol Soc; 2021 Nov; 2021():1731-1734. PubMed ID: 34891621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Harnessing synthetic lethality to predict the response to cancer treatment.
    Lee JS; Das A; Jerby-Arnon L; Arafeh R; Auslander N; Davidson M; McGarry L; James D; Amzallag A; Park SG; Cheng K; Robinson W; Atias D; Stossel C; Buzhor E; Stein G; Waterfall JJ; Meltzer PS; Golan T; Hannenhalli S; Gottlieb E; Benes CH; Samuels Y; Shanks E; Ruppin E
    Nat Commun; 2018 Jun; 9(1):2546. PubMed ID: 29959327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SL
    Liu Y; Wu M; Liu C; Li XL; Zheng J
    IEEE/ACM Trans Comput Biol Bioinform; 2020; 17(3):748-757. PubMed ID: 30969932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Computational methods, databases and tools for synthetic lethality prediction.
    Wang J; Zhang Q; Han J; Zhao Y; Zhao C; Yan B; Dai C; Wu L; Wen Y; Zhang Y; Leng D; Wang Z; Yang X; He S; Bo X
    Brief Bioinform; 2022 May; 23(3):. PubMed ID: 35352098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overcoming selection bias in synthetic lethality prediction.
    Seale C; Tepeli Y; Gonçalves JP
    Bioinformatics; 2022 Sep; 38(18):4360-4368. PubMed ID: 35876858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthetic lethality on drug discovery: an update on cancer therapy.
    Yar MS; Haider K; Gohel V; Siddiqui NA; Kamal A
    Expert Opin Drug Discov; 2020 Jul; 15(7):823-832. PubMed ID: 32228106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of synthetic lethal interactions from large-scale pan-cancer perturbation screens.
    Srivatsa S; Montazeri H; Bianco G; Coto-Llerena M; Marinucci M; Ng CKY; Piscuoglio S; Beerenwinkel N
    Nat Commun; 2022 Dec; 13(1):7748. PubMed ID: 36517508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An update on small molecule compounds targeting synthetic lethality for cancer therapy.
    Luo J; Li Y; Zhang Y; Wu D; Ren Y; Liu J; Wang C; Zhang J
    Eur J Med Chem; 2024 Nov; 278():116804. PubMed ID: 39241482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NSF4SL: negative-sample-free contrastive learning for ranking synthetic lethal partner genes in human cancers.
    Wang S; Feng Y; Liu X; Liu Y; Wu M; Zheng J
    Bioinformatics; 2022 Sep; 38(Suppl_2):ii13-ii19. PubMed ID: 36124790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. KG4SL: knowledge graph neural network for synthetic lethality prediction in human cancers.
    Wang S; Xu F; Li Y; Wang J; Zhang K; Liu Y; Wu M; Zheng J
    Bioinformatics; 2021 Jul; 37(Suppl_1):i418-i425. PubMed ID: 34252965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Link synthetic lethality to drug sensitivity of cancer cells.
    Wang R; Han Y; Zhao Z; Yang F; Chen T; Zhou W; Wang X; Qi L; Zhao W; Guo Z; Gu Y
    Brief Bioinform; 2019 Jul; 20(4):1295-1307. PubMed ID: 29300844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multi-omics characterization of synthetic lethality-related molecular features: implications for SL-based therapeutic target screening.
    Weng S; Ruan H
    FEBS J; 2023 Mar; 290(6):1477-1480. PubMed ID: 36461713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthetic lethal connectivity and graph transformer improve synthetic lethality prediction.
    Fan K; Gökbağ B; Tang S; Li S; Huang Y; Wang L; Cheng L; Li L
    Brief Bioinform; 2024 Jul; 25(5):. PubMed ID: 39210507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SL-Miner: a web server for mining evidence and prioritization of cancer-specific synthetic lethality.
    Liu X; Hu J; Zheng J
    Bioinformatics; 2024 Feb; 40(2):. PubMed ID: 38244572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PARP inhibitors: Synthetic lethality in the clinic.
    Lord CJ; Ashworth A
    Science; 2017 Mar; 355(6330):1152-1158. PubMed ID: 28302823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Embracing synthetic lethality of novel anticancer therapies.
    Kamal A; Shaik TB; Malik MS
    Expert Opin Drug Discov; 2015 Oct; 10(10):1119-32. PubMed ID: 26211783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthetic lethality prediction in DNA damage repair, chromatin remodeling and the cell cycle using multi-omics data from cell lines and patients.
    Markowska M; Budzinska MA; Coenen-Stass A; Kang S; Kizling E; Kolmus K; Koras K; Staub E; Szczurek E
    Sci Rep; 2023 Apr; 13(1):7049. PubMed ID: 37120674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SL-scan identifies synthetic lethal interactions in cancer using metabolic networks.
    Zangene E; Marashi SA; Montazeri H
    Sci Rep; 2023 Sep; 13(1):15763. PubMed ID: 37737478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.